BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31502692)

  • 21. Physiologically-Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug-Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations.
    Taskar KS; Pilla Reddy V; Burt H; Posada MM; Varma M; Zheng M; Ullah M; Emami Riedmaier A; Umehara KI; Snoeys J; Nakakariya M; Chu X; Beneton M; Chen Y; Huth F; Narayanan R; Mukherjee D; Dixit V; Sugiyama Y; Neuhoff S
    Clin Pharmacol Ther; 2020 May; 107(5):1082-1115. PubMed ID: 31628859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological-based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20-years; in-depth analysis of applications, organizations, and platforms.
    El-Khateeb E; Burkhill S; Murby S; Amirat H; Rostami-Hodjegan A; Ahmad A
    Biopharm Drug Dispos; 2021 Apr; 42(4):107-117. PubMed ID: 33325034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.
    Rodieux F; Gotta V; Pfister M; van den Anker JN
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S173-92. PubMed ID: 27385174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation.
    Ladumor MK; Thakur A; Sharma S; Rachapally A; Mishra S; Bobe P; Rao VK; Pammi P; Kangne H; Levi D; Balhara A; Ghandikota S; Joshi A; Nautiyal V; Prasad B; Singh S
    Sci Rep; 2019 Jul; 9(1):9709. PubMed ID: 31273226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
    Varma MV; El-Kattan AF
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin-Containing Monooxygenase 3 Maturational Changes Over Time.
    Nguyen PTT; Parvez MM; Kim MJ; Ho Lee J; Ahn S; Ghim JL; Shin JG
    J Clin Pharmacol; 2018 Oct; 58(10):1347-1360. PubMed ID: 29878384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontogeny of Phase I Metabolism of Drugs.
    Allegaert K; van den Anker J
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S33-S41. PubMed ID: 31502685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Pediatric Drug Disposition-Present and Future Directions of Pediatric Physiologically-Based Pharmacokinetics.
    Miyagi SJ; Long-Boyle JR
    Drug Metab Lett; 2015; 9(2):80-7. PubMed ID: 26031462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and Infants.
    Duan P; Fisher JW; Yoshida K; Zhang L; Burckart GJ; Wang J
    Clin Pharmacokinet; 2017 Apr; 56(4):383-394. PubMed ID: 27596256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches.
    Guo Y; Chu X; Parrott NJ; Brouwer KLR; Hsu V; Nagar S; Matsson P; Sharma P; Snoeys J; Sugiyama Y; Tatosian D; Unadkat JD; Huang SM; Galetin A;
    Clin Pharmacol Ther; 2018 Nov; 104(5):865-889. PubMed ID: 30059145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development.
    Leeder JS; Meibohm B
    Drug Metab Dispos; 2016 Jul; 44(7):916-23. PubMed ID: 27302933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.
    Scotcher D; Jones C; Posada M; Rostami-Hodjegan A; Galetin A
    AAPS J; 2016 Sep; 18(5):1067-1081. PubMed ID: 27365096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug disposition and clinical practice in neonates: cross talk between developmental physiology and pharmacology.
    Smits A; Annaert P; Allegaert K
    Int J Pharm; 2013 Aug; 452(1-2):8-13. PubMed ID: 22504091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologically based pharmacokinetic (PBPK) modeling in children.
    Barrett JS; Della Casa Alberighi O; Läer S; Meibohm B
    Clin Pharmacol Ther; 2012 Jul; 92(1):40-9. PubMed ID: 22669290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
    Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
    Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 enzymes in the pediatric population: Connecting knowledge on P450 expression with pediatric pharmacokinetics.
    Emoto C; Johnson TN
    Adv Pharmacol; 2022; 95():365-391. PubMed ID: 35953161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
    Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N
    Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.
    Zheng L; Xu M; Tang SW; Song HX; Jiang XH; Wang L
    Pharm Res; 2019 Oct; 36(12):171. PubMed ID: 31654287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review.
    Saeheng T; Na-Bangchang K; Karbwang J
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1365-1376. PubMed ID: 29978293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.